EPIC4ND—European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases
European Journal of Epidemiology · 22.07.2026
DOI: 10.1007/s10654-026-01430-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Epidemiology, online erschienen am 22.07.2026. Verfasst von Christina M Lill und 44 weiteren Autor:innen. Beteiligte Einrichtung: Translational Epidemiology Unit, Institute of Epidemiology and Social Medicine, University of Münster, Domagkstr. 3, Münster, Germany. christina.lill…. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Joint Programme - Neurodegenerative Disease Research, Instituto de Investigación Biosanitaria ibs.GRANADA, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The ‘European Prospective Investigation into Cancer and Nutrition’ cohort (EPIC) is a prospective study including ~ 520,000 participants recruited across Europe (1991–2000) with in-depth baseline data on nutritional, lifestyle, medical, and anthropometric variables, and baseline blood samples. Here we introduce EPIC4ND, a case-cohort study within EPIC designed to identify biomarkers predicting a future onset of dementia, Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). EPIC4ND comprises 6415 initially non-diseased participants (aged 35–80 years, mean age at baseline: 54 ± 9, 64% women) including 1899 incident cases with up to 30 years of follow-up and data on at least one omics domain available from pre-disease blood samples. EPIC4ND includes 4604 subcohort members (4441 non-cases and 163 incident cases) and 1811 additional incident cases ascertained from the broader EPIC cohort. Among the incident cases, there are 1190 dementia cases (818 AD ), 610 PD cases, and 199 ALS cases. Additionally, 72 prevalent PD cases and 118 incident Parkinsonism cases are available for comparison. Molecular data generated encompass proteomics, genome-wide DNA methylation, and SNP genotyping with 4127 EPIC4ND participants (including 1635 incident cases) having data on all three domains. Smaller studies include data on metals, metabolites, and environmental chemicals, while ongoing efforts focus on ultrasensitive targeted biomarker measurements and small RNA sequencing. Genome-wide association studies and analyses of epidemiological risk factors validate the dataset by confirming many known risk factors. Leveraging these extensive pre-disease multi-layered omics data offers a unique opportunity to identify biomarker signatures predicting neurodegenerative diseases and to explore their interplay with epidemiological risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Epidemiology Unit, Institute of Epidemiology and Social Medicine, University of Münster, Domagkstr. 3, Münster, Germany. christina.lill@uni-muenster.de.
- Ageing and Epidemiology Unit (AGE), School of Public Health, Imperial College London, London, UK. christina.lill@uni-muenster.de.
- Translational Epidemiology Unit, Institute of Epidemiology and Social Medicine, University of Münster, Domagkstr. 3, Münster, Germany.
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
- International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
- Department of Epidemiology, Murcia Regional Health Council-IMIB, Murcia, Spain.
Förderung
- EU Joint Programme - Neurodegenerative Disease Research
- Instituto de Investigación Biosanitaria ibs.GRANADA
- Deutsche Forschungsgemeinschaft
- Michael J Fox Foundation
- World Health Organization
- Cure Alzheimer's Fund
- Cure Alzheimer’s Fund
- CReATe- Clinical Research in ALS and Related Disorders for Therapeutic Development Consortium/NIH
Zitieren
APA
Lill, C. M., Homann, J., Ohlei, O., Smith-Byrne, K., Viallon, V., Huerta, J. M., Artaud, F., Zhao, Y., Britten, A., Deecke, L., Dobricic, V., Mokoroa, O., Guevara, M., Petrova, D., Trupp, M., Sabin, J., Gröninger, M., Colorado-Yohar, S. M., Alonso-Martin, S., …, & Riboli, E. (2026). EPIC4ND—European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases. European Journal of Epidemiology. https://doi.org/10.1007/s10654-026-01430-1
Vancouver
Lill CM, Homann J, Ohlei O, Smith-Byrne K, Viallon V, Huerta JM, et al. EPIC4ND—European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases. European Journal of Epidemiology. 2026. doi:10.1007/s10654-026-01430-1
BibTeX
@article{Lill2026,
author = {Lill, Christina M and Homann, Jan and Ohlei, Olena and Smith-Byrne, Karl and Viallon, Vivian and Huerta, Jose Maria and Artaud, Fanny and Zhao, Yujia and Britten, Abigail and Deecke, Laura and Dobricic, Valerija and Mokoroa, Olatz and Guevara, Marcela and Petrova, Dafina and Trupp, Miles and Sabin, Jara and Gröninger, Mareike and Colorado-Yohar, Sandra M and Alonso-Martin, Sonia and Cabrera-Castro, Natalia and Groppa, Sergiu and Robinson, Oliver and Hansen, Johnni and Eriksson, Sture and Sieri, Sabina and Jimenez, Ana and Tong, Tammy Y N and Kaaks, Rudolph and Severi, Gianluca and Travis, Ruth and Wareham, Nick and Benedet, Andréa L and Zetterberg, Henrik and Franke, Andre and Elbaz, Alexis and Bertram, Lars and Vermeulen, Roel and Middleton, Lefkos and Masala, Giovanna and Sacerdote, Carlotta and Peters, Susan and Katzke, Verena and Ferrari, Pietro and Gunter, Marc J and Riboli, Elio},
title = {EPIC4ND—European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases},
journal = {European Journal of Epidemiology},
year = {2026},
doi = {10.1007/s10654-026-01430-1}
}
EUVIMED